HETEROGENEITY OF THE TYPE I INTERFERON SIGNATURE IN RHEUMATOID ARTHRITIS MAY ACCOUNT FOR DIFFERENCES IN ITS CLINICAL RELEVANCE

被引：0
|
作者：
Rodriguez-Carrio, J. [1 ,2 ]
Alperi-Lopez, M. [2 ,3 ]
Lopez, P. [1 ,2 ]
Ballina-Garcia, F. J. [2 ,3 ]
Suarez, A. [1 ,2 ]
机构：
[1] Univ Oviedo, Area Immunol, Oviedo, Spain
[2] Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain
[3] Hosp Univ Cent Asturias, Dept Rheumatol, Oviedo, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.3195
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0041
引用
收藏
页码：1220 / 1221
页数：2
相关论文
共 50 条
  • [21] The type I IFN signature as a biomarker of preclinical rheumatoid arthritis
    Luebbers, Joyce
    Brink, Mikael
    de Stadt, Lotte A. van
    Vosslamber, Saskia
    Wesseling, John G.
    van Schaardenburg, Dirkjan
    Rantapaa-Dahlqvist, Solbritt
    Verweij, Cornelis L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (05) : 776 - 780
  • [22] REGULATION OF TYPE I INTERFERON SIGNATURE BY VGLL3 IN THE FIBROBLAST-LIKE SYNOVIOCYTES OF RHEUMATOID ARTHRITIS
    Du, Y.
    Dai, S. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1162 - 1162
  • [23] Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters
    de Jong, Tamarah D.
    Blits, Marjolein
    de Ridder, Sander
    Vosslamber, Saskia
    Wolbink, Gertjan
    Nurmohamed, Mike T.
    Verweij, Cornelis L.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [24] Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters
    Tamarah D. de Jong
    Marjolein Blits
    Sander de Ridder
    Saskia Vosslamber
    Gertjan Wolbink
    Mike T. Nurmohamed
    Cornelis L. Verweij
    Arthritis Research & Therapy, 18
  • [25] Activation of the type I interferon response in rheumatoid arthritis: Role of interferon regulatory factors
    Sweeney, Susan E.
    Kimbler, Trevor B.
    Firestein, Gary S.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S296 - S296
  • [26] The type I interferon signature determines the sustained anticitrullinated protein antibodies levels during TNFα blockade in rheumatoid arthritis
    Cantaert, Tineke
    van Baarsen, Lisa G.
    Wijbrandts, Carla A.
    van de Sande, Marleen G.
    Kraan, Tineke van der Pouw
    Verweij, Cor L.
    Tak, Paul P.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S517 - S517
  • [27] An Early Economic Evaluation Of Personalized Treatment With Rituximab By Prediction Of Effectiveness Using The Interferon Type I Signature In Rheumatoid Arthritis
    Nair, Sandhya C.
    Welsing, P. M. J.
    Vosslamber, Saskia
    Voskuyl, A. E.
    Nurmohamed, M. T.
    Bijlsma, J. W. J.
    Lafeber, Floris
    Verweij, Cornelis L.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S616 - S616
  • [28] Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjogren's syndrome
    Quartuccio, L.
    Mavragani, C. P.
    Nezos, A.
    Gandolfo, S.
    Tzioufas, A. G.
    De Vita, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (04) : 719 - +
  • [29] Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
    Kraan, T. C. T. M. van der Pouw
    Wijbrandts, C. A.
    van Baarsen, L. G. M.
    Voskuyl, A. E.
    Rustenburg, F.
    Baggen, J. M.
    Ibrahim, S. M.
    Fero, M.
    Dijkmans, B. A. C.
    Tak, P. P.
    Verweij, C. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (08) : 1008 - 1014
  • [30] Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: Assignment of a type I interferon signature in a subpopulation of patients
    Kraan, T. C. T. M. van der Pouw
    Wijbrandts, C. A.
    van Baarsen, L. G.
    Voskuyl, A. E.
    Rustenburg, F.
    Baggen, J. M.
    Fero, M.
    Dijkmans, B. A. C.
    Tak, P. P.
    Verweij, C. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A8 - A8
12345